Topiramate Tablet
Product Images NDC 63187-963

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Topiramate (NDC 63187-963). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Topi (6491d395 Ef69 4db7 Abe1 87f061db14d8 01)

Topi (6491d395 Ef69 4db7 Abe1 87f061db14d8 01)
Chemical structure of Topiramate showing the molecular arrangement with functional groups including sulfonamide and multiple oxygen-containing rings.*
FDA Label Image

Topi (6491d395 Ef69 4db7 Abe1 87f061db14d8 02)

Topi (6491d395 Ef69 4db7 Abe1 87f061db14d8 02)
A Kaplan-Meier plot showing cumulative rates over time with two comparative lines. The y-axis represents cumulative rates, and the x-axis represents time in days. A p-value of 0.0002 is noted on the graph, indicating statistical analysis between the two groups.*
FDA Label Image

Figure 2: Reduction In 4-week Migraine Headache Frequency (studies 10 And 11 For Adults And Adolescents) (6491d395 Ef69 4db7 Abe1 87f061db14d8 03)

Figure 2: Reduction In 4-week Migraine Headache Frequency (studies 10 And 11 For Adults And Adolescents) (6491d395 Ef69 4db7 Abe1 87f061db14d8 03)
Bar chart comparing changes from baseline to double-blind phase in average weekly migraine period days across treatment groups: Placebo, Topamax 50 mg/day, 100 mg/day, and 200 mg/day. Data are shown for two studies (10 and 11), with statistical significance indicated for Topamax 100 mg/day and 200 mg/day doses.*
FDA Label Image

63187-963-30 (6491d395 Ef69 4db7 Abe1 87f061db14d8 07)

63187-963-30 (6491d395 Ef69 4db7 Abe1 87f061db14d8 07)
Label for Topiramate 200 mg tablets by Proficient Rx LP, featuring product details for 30 tablets. The label states the active ingredient strength as 200 mg per tablet and describes the tablets as pink, capsule-shaped, biconvex, film-coated, with debossed markings. Manufacturer is Cipla Ltd., Kurkumbh, India. Storage and safety instructions are included, along with lot, expiration, and NDC 63187-963-30 information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.